{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2022,5,27]],"date-time":"2022-05-27T17:07:29Z","timestamp":1653671249795},"reference-count":26,"publisher":"Elsevier BV","issue":"35","license":[{"start":{"date-parts":[[2008,8,1]],"date-time":"2008-08-01T00:00:00Z","timestamp":1217548800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Vaccine"],"published-print":{"date-parts":[[2008,8]]},"DOI":"10.1016\/j.vaccine.2008.06.051","type":"journal-article","created":{"date-parts":[[2008,7,4]],"date-time":"2008-07-04T10:53:29Z","timestamp":1215168809000},"page":"4486-4493","source":"Crossref","is-referenced-by-count":16,"title":["European Sero-Epidemiology Network 2: Standardisation of immunoassay results for pertussis requires homogeneity in the antigenic preparations"],"prefix":"10.1016","volume":"26","author":[{"given":"Anna","family":"Giammanco","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Antony","family":"Nardone","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Richard","family":"Pebody","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"George","family":"Kafatos","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nick","family":"Andrews","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alfredo","family":"Chiarini","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Susanna","family":"Taormina","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fernando","family":"de Ory","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Katarina","family":"Prosenc","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bohumir","family":"Krize","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hans","family":"Hallander","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Margaretha","family":"Ljungman","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Esther","family":"Marva","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Athanassios","family":"Tsakris","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Darina","family":"O\u2019Flanagan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fran\u00e7ois","family":"Schneider","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Algirdas","family":"Griskevicius","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Robert","family":"Vranckx","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ildiko","family":"Karacs","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.vaccine.2008.06.051_bib1","doi-asserted-by":"crossref","first-page":"29","DOI":"10.2807\/esm.02.04.00167-en","article-title":"The European sero-epidemiology network","volume":"2","author":"Osborne","year":"1997","journal-title":"Eurosurveillance"},{"key":"10.1016\/j.vaccine.2008.06.051_bib2","doi-asserted-by":"crossref","first-page":"5022","DOI":"10.1016\/j.vaccine.2005.05.030","article-title":"Model selection methodology for inter-laboratory standardisation of antibody titres","volume":"23","author":"Kafatos","year":"2005","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2008.06.051_bib3","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1017\/S0950268899004161","article-title":"The sero-epidemiology of diphtheria in Western Europe","volume":"125","author":"Edmunds","year":"2000","journal-title":"Epidemiol Infect"},{"key":"10.1016\/j.vaccine.2008.06.051_bib4","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1017\/S0950268899004574","article-title":"The seroepidemiology of rubella in Western Europe","volume":"125","author":"Pebody","year":"2000","journal-title":"Epidemiol Infect"},{"key":"10.1016\/j.vaccine.2008.06.051_bib5","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1017\/S0950268801005234","article-title":"The seroepidemiology of measles in Western Europe","volume":"126","author":"de Melker","year":"2001","journal-title":"Epidemiol Infect"},{"key":"10.1016\/j.vaccine.2008.06.051_bib6","doi-asserted-by":"crossref","first-page":"691","DOI":"10.1017\/S0950268803008768","article-title":"Sero-epidemiology of mumps in western Europe","volume":"131","author":"Nardone","year":"2003","journal-title":"Epidemiol Infect"},{"key":"10.1016\/j.vaccine.2008.06.051_bib7","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1136\/sti.2003.005850","article-title":"The seroepidemiology of herpes simplex virus type 1 and 2 in Europe","volume":"80","author":"Pebody","year":"2004","journal-title":"Sex Transm Infect"},{"key":"10.1016\/j.vaccine.2008.06.051_bib8","doi-asserted-by":"crossref","first-page":"5","DOI":"10.2807\/esm.09.04.00456-en","article-title":"Serological surveillance of rubella in Europe: European Sero-Epidemiology Network (ESEN2)","volume":"9","author":"Nardone","year":"2004","journal-title":"Eurosurveillance"},{"key":"10.1016\/j.vaccine.2008.06.051_bib9","doi-asserted-by":"crossref","first-page":"1314","DOI":"10.1016\/j.vaccine.2003.08.039","article-title":"Sero-epidemiology of Bordetella pertussis in England and Wales","volume":"22","author":"Nardone","year":"2004","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2008.06.051_bib10","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1017\/S0950268804003012","article-title":"The seroepidemiology of Bordetella pertussis infection in Western Europe","volume":"133","author":"Pebody","year":"2005","journal-title":"Epidemiol Infect"},{"key":"10.1016\/j.vaccine.2008.06.051_bib11","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1017\/S0950268899004173","article-title":"The European Sero-Epidemiology Network: standardizing the enzyme immunoassay results for measles, mumps and rubella","volume":"125","author":"Andrews","year":"2000","journal-title":"Epidemiol Infect"},{"key":"10.1016\/j.vaccine.2008.06.051_bib12","doi-asserted-by":"crossref","first-page":"3287","DOI":"10.1016\/S0264-410X(00)00125-0","article-title":"European Sero-Epidemiology Network: standardisation of the results of diphtheria antitoxin assays","volume":"18","author":"von Hunolstein","year":"2000","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2008.06.051_bib13","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1016\/j.jcv.2006.01.017","article-title":"European Sero-epidemiology Network 2: standardisation of assays for seroepidemiology of varicella zoster virus","volume":"36","author":"de Ory","year":"2006","journal-title":"J Clin Virol"},{"key":"10.1016\/j.vaccine.2008.06.051_bib14","doi-asserted-by":"crossref","DOI":"10.1017\/S0950268807008266","article-title":"Standardization of measles, mumps and rubella assays to enable comparisons of seroprevalence data across 21 European countries and Australia","author":"Tischer","year":"2007","journal-title":"Epidemiol Infect"},{"key":"10.1016\/j.vaccine.2008.06.051_bib15","doi-asserted-by":"crossref","first-page":"260","DOI":"10.1111\/j.1365-2893.2006.00789.x","article-title":"The European Sero-Epidemiology Network 2: standardization of assay results for hepatitis B virus","volume":"14","author":"Kafatos","year":"2007","journal-title":"J Viral Hepat"},{"key":"10.1016\/j.vaccine.2008.06.051_bib16","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1016\/S0264-410X(03)00514-0","article-title":"European Sero-Epidemiology Network: standardisation of the assay results for pertussis","volume":"22","author":"Giammanco","year":"2003","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2008.06.051_bib17","doi-asserted-by":"crossref","first-page":"2435","DOI":"10.1128\/JCM.35.10.2435-2443.1997","article-title":"Laboratory diagnosis of pertussis: state of the art in 1997","volume":"35","author":"M\u00fcller","year":"1997","journal-title":"J Clin Microbiol"},{"key":"10.1016\/j.vaccine.2008.06.051_bib18","doi-asserted-by":"crossref","first-page":"S288","DOI":"10.1086\/322564","article-title":"How to make sense of pertussis immunogenetic data","volume":"33","author":"Olin","year":"2001","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.vaccine.2008.06.051_bib19","doi-asserted-by":"crossref","first-page":"1907","DOI":"10.1016\/S0264-410X(98)00227-8","article-title":"Levels of anti-pertussis antibodies related to protection after household exposure to Bordetella pertussis","volume":"16","author":"Storsaeter","year":"1998","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2008.06.051_bib20","doi-asserted-by":"crossref","first-page":"1010","DOI":"10.1086\/315318","article-title":"Correlation between pertussis toxin IgG antibodies in postvaccination and subsequent protection against pertussis","volume":"181","author":"Taranger","year":"2000","journal-title":"J Infect Dis"},{"key":"10.1016\/j.vaccine.2008.06.051_bib21","doi-asserted-by":"crossref","first-page":"800","DOI":"10.1128\/JCM.38.2.800-806.2000","article-title":"Specificity and sensitivity of high levels of immunoglobulin G antibodies against pertussis toxin in a single serum sample for diagnosis of infection with Bordetella pertussis","volume":"38","author":"de Melker","year":"2000","journal-title":"J Clin Microbiol"},{"key":"10.1016\/j.vaccine.2008.06.051_bib22","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1017\/S0950268802007896","article-title":"Kinetics of IgG antibody response to pertussis toxin after infection with B. pertussis","volume":"129","author":"Teunis","year":"2002","journal-title":"Epidemiol Infect"},{"key":"10.1016\/j.vaccine.2008.06.051_bib23","first-page":"275","article-title":"Antibody kinetics and long-term sero-prevalence in the Italian clinical trial of acellular pertussis vaccines","volume":"89","author":"Giuliano","year":"1997","journal-title":"Dev Biol Stand"},{"key":"10.1016\/j.vaccine.2008.06.051_bib24","doi-asserted-by":"crossref","first-page":"983","DOI":"10.1016\/S0022-3476(98)70395-6","article-title":"Antibody responses and persistence in the 2 years after immunization with two acellular vaccines and one whole-cell vaccine against pertussis","volume":"132","author":"Giuliano","year":"1998","journal-title":"J Pediatr"},{"key":"10.1016\/j.vaccine.2008.06.051_bib25","series-title":"Manual of clinical laboratory and laboratory immunology","first-page":"388","article-title":"Serological responses to Bordetella pertussis","author":"Manclark","year":"1986"},{"key":"10.1016\/j.vaccine.2008.06.051_bib26","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1017\/S0950268804003206","article-title":"Correlation of IgA, IgM and IgG antibody-detecting assays based on filamentous haemagglutinin, pertussis toxin and Bordetella pertussis sonicate in a strictly adult population","volume":"133","author":"Klement","year":"2005","journal-title":"Epidemiol Infect"}],"container-title":["Vaccine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X08008013?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X08008013?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2020,5,6]],"date-time":"2020-05-06T21:01:09Z","timestamp":1588798869000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0264410X08008013"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2008,8]]},"references-count":26,"journal-issue":{"issue":"35","published-print":{"date-parts":[[2008,8]]}},"alternative-id":["S0264410X08008013"],"URL":"https:\/\/doi.org\/10.1016\/j.vaccine.2008.06.051","relation":{},"ISSN":["0264-410X"],"issn-type":[{"value":"0264-410X","type":"print"}],"subject":[],"published":{"date-parts":[[2008,8]]}}}